SAN DIEGO, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the closing of its previously announced registered direct offering priced at-the-marker under Nasdaq rules for the purchase and sale of an aggregate of 9,881,113 shares of its common stock and Series C warrants to purchase up to an aggregate of 9,881,113 shares of common stock and short-term Series D warrants to purchase up to an aggregate of 9,881,113 shares of common stock (collectively, the “Warrants”) at a ...

SINGAPORE, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Trident Digital Tech Holdings Ltd. (Nasdaq: TDTH) (“Trident” or the “Company”), a leading digital transformation enabler in the small and medium enterprise, or the SME segment of the e-commerce enablement and digital optimization services market in Singapore, today rang the Opening Bell of the Nasdaq exchange to celebrate the Company’s successful listing in the U.S. With shares of the Company trading under the ticker “TDTH” since September 10, 2024, this mileston ...

U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dipping around 500 points on Thursday.The Dow traded down 0.62% to 41,880.03 while the NASDAQ fell 2.69% to 18,107.65. The S&P 500 also fell, dropping, 1.64% to 5,718.50.Check This Out: Top 2 Real Estate Stocks You May Want To Dump This QuarterLeading and Lagging SectorsUtilities shares rose by 1.6% on Thursday.In trading on Thursday, information technology shares fell by 3.4%.Top HeadlineShares of Uber Technologies, Inc UBER dipp ...

SUNNYVALE, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (the "Company" or "23andMe"), a leading human genetics and preventive health company, today announced that the Company has regained compliance with the minimum closing bid price requirement under Nasdaq Listing Rule 5550(a)(2) and the majority independent board and various board committee requirements under Nasdaq Listing Rule 5605. Accordingly, the Company's Class A common stock will continue to be listed on The Nasdaq Ca ...

EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...

EnglishItalianoEspañolPortuguêsDeutschالعربيةFrançaisImportant DisclaimersThe content provided on the website includes general news and publications, our personal analysis and opinions, and contents provided by third parties, which are intended for educational and research purposes only. It does not constitute, and should not be read as, any recommendation or advice to take any action whatsoever, including to make any investment or buy any product. When making any financial decision, you should perform your ...

NEW YORK, Oct. 30, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, today announced that on October 29, 2024, the Company received written notice from The Nasdaq Stock Market stating that the Company has regained compliance with the minimum closing bid price requirement under Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market.Accordingly, the Company's common stock will continue to ...

GAITHERSBURG, Md., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) ("Shuttle Pharma" or the "Company"), a discovery and development stage specialty pharmaceutical company focused on improving outcomes for cancer patients treated with radiation therapy (RT), today announced the pricing of its "reasonable best efforts" public offering with a health-care focused institutional investor for the purchase and sale of up to 2,950,820 shares of common stock (or pre-funded warr ...

办公空间管理 - 公司正在评估实际办公空间需求,并已就此计提了2300万美元的减值费用[126] - 公司未来5年的租赁付款总额为5.46亿美元,其中2025年为7300万美元[127] 业务重组 - 公司已将业务重组为三大板块:资本准入平台、金融科技和市场服务[136] - 公司预计将在2023年第四季度完成Adenza收购后启动重组计划,预计将产生约8000万美元的税前重组费用[141] - 公司在2022年10月启动了部门调整计划,截至2024年9月30日已完成该计划并确认了总计1.39亿美元的税前费用[141] 财务表现 - 2024年前三季度,公司总收入减去交易费用为34.22亿美元,同比增长23.2%[149] - 2024年前三季度,公司营业收入为12.81亿美元,同比增长4.5%[149] - 2024年前三季度,公司归属于纳斯达克的净利润为7.62亿美元,同比下降11.6%[149] - 2024年第三季度,公司总收入减去交易费用为11.46亿美元,同比增长21.9%[148] - 2024年第三季度,公司营业收入为4.48亿美元,同比增长3.7%[148] - 2024年第三季度,公司归属于纳斯达克的净利润为3.06亿美元,同比增长3.9%[148] 业务指标 - 公司ARR(年经常性收入)为关键业务指标之一,反映了公司经常性业务的健康状况和发展趋势[150][151] - 公司SaaS(软件即服务)收入在2024年第三季度为8.72亿美元,同比增长31.0%[153] - 数据和上市服务收入在第三季度和前九个月同比增长1.0%和0.5%[156] - 指数收入在第三季度和前九个月同比分别增长26.4%和35.3%[157] - 工作流和洞察收入在第三季度和前九个月同比分别增长3.6%和3.8%[156] - 资本市场技术收入在第三季度和前九个月同比分别增长61.6%和67.7%[161] - 监管技术收入在第三季度和前九个月同比分别增长92.2%和148.5%[160] - 金融犯罪管理技术收入在第三季度和前九个月同比分别增长19.8%和22.1%[159] - 截至2024年9月30日,ARR达到12.54亿美元,较2023年9月30日增长2.6%[156] - 截至2024年9月30日,上市公司总数为5,225家,较2023年9月30日减少97家[156] - 第三季度和前九个月,新上市公司数量分别为138家和301家,较2023年同期分别增加51家和71家[156] - 第三季度和前九个月,ETF跟踪纳斯达克指数的AUM分别为5,750亿美元和5,750亿美元,较2023年同期分别增长35.9%和35.9%[158] 市场服务业务 - 市场服务业务收入为10.22亿美元，同比增长36.7%[162] - 交易佣金和清算费用增加278.1%，主要由于行业交易量增加[162] - 美国股票期权交易量增加12.2%，但纳斯达克交易所的市场份额有所下降[168][169] - 现货股票交易收入增加11.7%，主要由于行业交易量增加，但纳斯达克交易所的市场份额略有下降[169][170] - 美国股票交易数据收入基本持平，受行业交易量下降和一次性调整的影响[175] - 其他业务收入在2024年第三季度和前九个月同比有所增长，主要由于北欧固定收益交易和清算以及加拿大现金股票交易收入增加[176][177] - 公司于2023年6月宣布出售北欧电力交易和清算业务，但于2024年6月终止该交易，该业务的收入将继续计入其他收入[178] 运营成本 - 公司运营费用在2024年第三季度和前九个月同比大幅增加,主要由于Adenza并购带来的人员成本、专业服务费用和技术费用增加[180][182] - 公司于2024年完成了Adenza重组计划,预计可实现8000万美元的净费用协同效应,截至2024年9月30日已实现约80%[183] - 公司还实施了部门调整计划,预计到2025年可实现约3000万美元的年度运营效率[183] 财务费用 - 利息收入在2024年第三季度和前九个月同比大幅下降,主要由于平均现金余额下降[185] - 利息费用在2024年前九个月同比大幅增加,主要由于2023年6月发行债券用于Adenza收购[185][187] 税务 - 公司2024年前三季度的有效税率为24.8%,主要由于最近收购事项和通过通胀减免法案获得的能源税收抵免导致美国境外收入的税收减少[130] - 公司2024年第三季度和前九个月的有效税率分别为24.8%和23.3%[187] 监管合规 - 公司正在与监管机构就监管检查等事项进行沟通,但尚未确定最终结果和可能产生的影响[136]

NEW YORK, Oct. 29, 2024 /PRNewswire/ -- Cineverse (Nasdaq: CNVS), an innovative streaming entertainment and technology company, will visit the Nasdaq MarketSite in Times Square on October 31, 2024.To celebrate the recent box office success of independent slasher hit movie, Terrifier 3— distributed by Cineverse — the company has asked the film's iconic character Art the Clown to ring the Closing Bell.Also joining him on Halloween will be Cineverse executives and guests, including representatives from Terrifi ...